Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual

Introduction: 4-fluoroamphetamine (4-FA) is a novel psychoactive stimulant with a global presence on the drug market. Despite the popularity of 4-FA, data on severe adverse effects are scarce. We present a case of laboratory confirmed 4-FA mono intoxication causing acute heart failure due to a rever...

Full description

Bibliographic Details
Main Authors: R.S.D. van der Pas, F.M.J. Gresnigt, L. Wansink, E.J.F. Franssen, R.K. Riezebos
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Toxicology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750020304455
_version_ 1818647815608336384
author R.S.D. van der Pas
F.M.J. Gresnigt
L. Wansink
E.J.F. Franssen
R.K. Riezebos
author_facet R.S.D. van der Pas
F.M.J. Gresnigt
L. Wansink
E.J.F. Franssen
R.K. Riezebos
author_sort R.S.D. van der Pas
collection DOAJ
description Introduction: 4-fluoroamphetamine (4-FA) is a novel psychoactive stimulant with a global presence on the drug market. Despite the popularity of 4-FA, data on severe adverse effects are scarce. We present a case of laboratory confirmed 4-FA mono intoxication causing acute heart failure due to a reverse type Takotsubo cardiomyopathy. Case: A 20-year-old male with no previous medical history and no reported previous drug use, presented to the emergency department (ED) with complaints of headache, nausea and vomiting, approximately 4.5 h after the ingestion of a single 4-FA pill. After 30 min his condition deteriorated with severe hypertension, tachycardia and respiratory failure. Echocardiography showed a reverse type Takotsubo cardiomyopathy. The patient was successfully treated with mechanical ventilation, a phosphodiesterase-3-inhibitor (PDE3-inhibitor) and diuretics. Three months after hospital admission, the patient was free of complaints and his left ventricular function fully recovered. Conclusion: Recreational use of 4-FA may result in acute onset life-threatening cardiorespiratory toxicity, preceded by severe hypertension, even in drug-naïve patients without any medical history. Emergency physicians and cardiologists should be cautious not to underestimate life-threatening 4-FA complications.
first_indexed 2024-12-17T01:08:32Z
format Article
id doaj.art-c17f5c31179146539714ae8edc1a413c
institution Directory Open Access Journal
issn 2214-7500
language English
last_indexed 2024-12-17T01:08:32Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series Toxicology Reports
spelling doaj.art-c17f5c31179146539714ae8edc1a413c2022-12-21T22:09:12ZengElsevierToxicology Reports2214-75002020-01-01716291633Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individualR.S.D. van der Pas0F.M.J. Gresnigt1L. Wansink2E.J.F. Franssen3R.K. Riezebos4Emergency medicine at OLVG hospital, Amsterdam, the Netherlands; Emergency registrars at Sint Antonius hospital, Nieuwegein, the NetherlandsEmergency Physician at OLVG Hospital, Amsterdam, the Netherlands; Corresponding author at: Emergency physician at OLVG hospital, Oosterpark 9, 1091 AC, Amsterdam, the Netherlands.Emergency medicine at OLVG hospital, Amsterdam, the Netherlands; Emergency Physician at Dijklander ziekenhuis, Hoorn, the NetherlandsPharmacist at OLVG Hospital, Amsterdam, the NetherlandsCardiologist at OLVG Hospital, Amsterdam, the NetherlandsIntroduction: 4-fluoroamphetamine (4-FA) is a novel psychoactive stimulant with a global presence on the drug market. Despite the popularity of 4-FA, data on severe adverse effects are scarce. We present a case of laboratory confirmed 4-FA mono intoxication causing acute heart failure due to a reverse type Takotsubo cardiomyopathy. Case: A 20-year-old male with no previous medical history and no reported previous drug use, presented to the emergency department (ED) with complaints of headache, nausea and vomiting, approximately 4.5 h after the ingestion of a single 4-FA pill. After 30 min his condition deteriorated with severe hypertension, tachycardia and respiratory failure. Echocardiography showed a reverse type Takotsubo cardiomyopathy. The patient was successfully treated with mechanical ventilation, a phosphodiesterase-3-inhibitor (PDE3-inhibitor) and diuretics. Three months after hospital admission, the patient was free of complaints and his left ventricular function fully recovered. Conclusion: Recreational use of 4-FA may result in acute onset life-threatening cardiorespiratory toxicity, preceded by severe hypertension, even in drug-naïve patients without any medical history. Emergency physicians and cardiologists should be cautious not to underestimate life-threatening 4-FA complications.http://www.sciencedirect.com/science/article/pii/S22147500203044554-FluoroamphetamineAdverse eventsReverse type Takotsubo cardiomyopathyCardiogenic shock
spellingShingle R.S.D. van der Pas
F.M.J. Gresnigt
L. Wansink
E.J.F. Franssen
R.K. Riezebos
Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual
Toxicology Reports
4-Fluoroamphetamine
Adverse events
Reverse type Takotsubo cardiomyopathy
Cardiogenic shock
title Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual
title_full Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual
title_fullStr Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual
title_full_unstemmed Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual
title_short Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual
title_sort acute onset heart failure due to reverse type takotsubo cardiomyopathy caused by a single dose of 4 fluoroamphetamine in a healthy young individual
topic 4-Fluoroamphetamine
Adverse events
Reverse type Takotsubo cardiomyopathy
Cardiogenic shock
url http://www.sciencedirect.com/science/article/pii/S2214750020304455
work_keys_str_mv AT rsdvanderpas acuteonsetheartfailureduetoreversetypetakotsubocardiomyopathycausedbyasingledoseof4fluoroamphetamineinahealthyyoungindividual
AT fmjgresnigt acuteonsetheartfailureduetoreversetypetakotsubocardiomyopathycausedbyasingledoseof4fluoroamphetamineinahealthyyoungindividual
AT lwansink acuteonsetheartfailureduetoreversetypetakotsubocardiomyopathycausedbyasingledoseof4fluoroamphetamineinahealthyyoungindividual
AT ejffranssen acuteonsetheartfailureduetoreversetypetakotsubocardiomyopathycausedbyasingledoseof4fluoroamphetamineinahealthyyoungindividual
AT rkriezebos acuteonsetheartfailureduetoreversetypetakotsubocardiomyopathycausedbyasingledoseof4fluoroamphetamineinahealthyyoungindividual